# GE HealthCare completes acquisition of remaining stake in Nihon Medi-Physics

GE HealthCare has completed its acquisition of the remaining 50% stake in Nihon Medi-Physics Co., Ltd (NMP) from Sumitomo Chemical, giving it full ownership. NMP is a leading radiopharmaceutical company in Japan.

- Type: Acquisition
- Announced: 2025-03-31
- Where: Tokyo, Japan, Japan
- Status: completed
- Products: radiopharmaceuticals for SPECT and PET molecular imaging
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Sumitomo Chemical](https://endata.com/companies/20503.md) (partner)
- [Nihon Medi-Physics Co. Ltd.](https://endata.com/companies/35628.md) (target)
- [GE HealthCare Technologies](https://endata.com/companies/68780.md) (acquirer)

## Sources

- [markets.financialcontent.com](https://markets.financialcontent.com/stocks/article/bizwire-2025-3-31-ge-healthcare-completes-acquisition-of-nihon-medi-physics-nmp-a-leading-radiopharmaceutical-company-in-japan), 2025-03-31: "We are delighted to welcome Nihon Medi-Physics to GE HealthCare, increasing our existing footprint and offering in Japan"

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.